IL145524A0 - Formulation comprising testosterone undecanoate and castor oil - Google Patents

Formulation comprising testosterone undecanoate and castor oil

Info

Publication number
IL145524A0
IL145524A0 IL14552400A IL14552400A IL145524A0 IL 145524 A0 IL145524 A0 IL 145524A0 IL 14552400 A IL14552400 A IL 14552400A IL 14552400 A IL14552400 A IL 14552400A IL 145524 A0 IL145524 A0 IL 145524A0
Authority
IL
Israel
Prior art keywords
castor oil
testosterone undecanoate
solution
liquid carrier
formulation
Prior art date
Application number
IL14552400A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL145524A0 publication Critical patent/IL145524A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL14552400A 1999-04-01 2000-03-27 Formulation comprising testosterone undecanoate and castor oil IL145524A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99302581 1999-04-01
PCT/EP2000/002677 WO2000059512A1 (fr) 1999-04-01 2000-03-27 Preparation comprenant de la testosterone undecanoate et de l'huile de ricin

Publications (1)

Publication Number Publication Date
IL145524A0 true IL145524A0 (en) 2002-06-30

Family

ID=8241306

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14552400A IL145524A0 (en) 1999-04-01 2000-03-27 Formulation comprising testosterone undecanoate and castor oil
IL145524A IL145524A (en) 1999-04-01 2001-09-20 Compositions containing testosterone undecanoate and castor oil

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145524A IL145524A (en) 1999-04-01 2001-09-20 Compositions containing testosterone undecanoate and castor oil

Country Status (27)

Country Link
EP (1) EP1189620B1 (fr)
JP (1) JP2002541111A (fr)
KR (1) KR100666016B1 (fr)
CN (1) CN1155385C (fr)
AT (1) ATE269708T1 (fr)
AU (1) AU768537B2 (fr)
BR (1) BR0009465A (fr)
CA (1) CA2366856C (fr)
CZ (1) CZ298573B6 (fr)
DE (1) DE60011771T2 (fr)
DK (1) DK1189620T3 (fr)
ES (1) ES2222199T3 (fr)
HK (1) HK1043544A1 (fr)
HU (1) HU229455B1 (fr)
ID (1) ID30481A (fr)
IL (2) IL145524A0 (fr)
MX (1) MXPA01009919A (fr)
NO (1) NO329420B1 (fr)
NZ (1) NZ514290A (fr)
PL (1) PL195163B1 (fr)
PT (1) PT1189620E (fr)
RU (1) RU2246296C2 (fr)
SK (1) SK286071B6 (fr)
TR (1) TR200102769T2 (fr)
TW (1) TWI280124B (fr)
WO (1) WO2000059512A1 (fr)
ZA (1) ZA200107781B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
GB9907715D0 (en) * 1999-04-01 1999-05-26 Scherer Corp R P Pharmaceutical compositions
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
PT1530965E (pt) 2003-11-11 2006-05-31 Udo Mattern Sistema de administracao de libertacao controlada de hormonas sexuais para aplicacao nasal
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
AU2006236564B2 (en) * 2005-04-15 2011-02-17 Tolmar, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
CN101600417B (zh) 2006-10-04 2012-05-30 M&P专利股份公司 用于神经递质的经鼻施用的控制释放递送系统
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
RU2012142997A (ru) * 2010-04-12 2014-06-20 Кларус Терапеутикс, Инк. Оральные фармацевтические композиции сложных эфиров тестостерона и способы лечения недостатка тестостерона с их использованием
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
AU2012209184B2 (en) * 2011-01-26 2017-06-15 Allergan, Inc. Androgen composition for treating an opthalmic condition
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
KR20170020779A (ko) 2014-06-17 2017-02-24 머크 샤프 앤 도메 비.브이. 테스토스테론 운데카노에이트의 안정한 제제
CN107073127A (zh) * 2014-06-19 2017-08-18 索露奥公司 亲脂性化合物的固体口服剂型
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (fr) 2014-08-28 2016-03-03 Lipocine Inc. Compositions de (17-ss)-3-oxoandrost-4-èn-17-yl tridécanoate et leurs procédés de préparation et d'utilisation
RU2017111503A (ru) * 2014-08-29 2018-10-05 Липосин Инк. КОМПОЗИЦИИ(17-β)-3-ОКСОАНДРОСТ-4-ЕН-17-ИЛ УНДЕКАНОАТА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
EP3544614A4 (fr) 2016-11-28 2020-08-05 Lipocine Inc. Traitement oral à base d'undécanoate de testostérone

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
GB9608719D0 (en) * 1996-04-26 1996-07-03 Scherer Ltd R P Pharmaceutical compositions
SE9700642D0 (sv) * 1997-02-24 1997-02-24 Kronvall Stefan Med Ab Medel och sätt för förebyggande och behandling av det metabola syndromet

Also Published As

Publication number Publication date
NO20014718L (no) 2001-09-28
NZ514290A (en) 2003-08-29
HU229455B1 (en) 2013-12-30
WO2000059512A1 (fr) 2000-10-12
HUP0200453A2 (hu) 2002-07-29
DE60011771T2 (de) 2004-11-04
JP2002541111A (ja) 2002-12-03
HK1043544A1 (en) 2002-09-20
NO20014718D0 (no) 2001-09-28
TWI280124B (en) 2007-05-01
EP1189620B1 (fr) 2004-06-23
MXPA01009919A (es) 2002-04-24
IL145524A (en) 2006-12-31
CN1346274A (zh) 2002-04-24
NO329420B1 (no) 2010-10-18
ZA200107781B (en) 2002-12-20
AU768537B2 (en) 2003-12-18
KR20010108435A (ko) 2001-12-07
KR100666016B1 (ko) 2007-01-10
CN1155385C (zh) 2004-06-30
ES2222199T3 (es) 2005-02-01
AU4111100A (en) 2000-10-23
DK1189620T3 (da) 2004-08-16
SK286071B6 (sk) 2008-02-05
CZ298573B6 (cs) 2007-11-14
PT1189620E (pt) 2004-10-29
PL195163B1 (pl) 2007-08-31
DE60011771D1 (de) 2004-07-29
CA2366856A1 (fr) 2000-10-12
CA2366856C (fr) 2006-05-16
PL351259A1 (en) 2003-04-07
ATE269708T1 (de) 2004-07-15
CZ20013507A3 (cs) 2002-03-13
RU2246296C2 (ru) 2005-02-20
EP1189620A1 (fr) 2002-03-27
ID30481A (id) 2001-12-13
TR200102769T2 (tr) 2002-05-21
SK13722001A3 (sk) 2002-02-05
HUP0200453A3 (en) 2003-06-30
BR0009465A (pt) 2002-01-08

Similar Documents

Publication Publication Date Title
IL145524A0 (en) Formulation comprising testosterone undecanoate and castor oil
RU2001129362A (ru) Композиция, включающая ундеканоат тестостерона и касторовое масло
GB9907715D0 (en) Pharmaceutical compositions
PL318560A1 (en) Novel orally administered preparations containing cyclosporin of simple composition and high bioavailability
EP0904064A1 (fr) Preparation pharmaceutique orale contenant des hormones sexuelles
KR950031069A (ko) 골손실의 억제 및 혈청 콜레스테롤의 강하 방법
CA2301017A1 (fr) Utilisation de gallate de propyle pour augmenter la biodisponibilite de produits pharmaceutiques administres par voie orale
US20050287203A1 (en) Formulation comprising testosteron undecanoate and castor oil
WO2000057918A2 (fr) Nouvelles formules comprenant des agents de regulation des lipides
CA2431397A1 (fr) Matrice lipide auto-emulsifiante (selm)
NO950134L (no) Formuleringer for oralt administrerte farmasöytiske midler
MXPA05008921A (es) Formulaciones orales semisolidas para liberacion inmediata que comprenden un agente hidrofobo anticancer, un glicerido poliglicolisado y un vehiculo hidrofilo.
AR023235A1 (es) Formulaciones de androgenos
AU3043400A (en) Cyclosporin solution
US20060024341A1 (en) Microemulsion composition and related method
TH33003B (th) สูตรตำรับแอนโดรเจน
TH60756A (th) สูตรตำรับแอนโดรเจน
TH34374B (th) องค์ประกอบเชิงเภสัชกรรมชนิดที่เป็นของแข็งซึ่งประกอบด้วยอนุพันธ์เบนโซฟูแรน
TH40043A (th) องค์ประกอบเชิงเภสัชกรรมชนิดที่เป็นของแข็งซึ่งประกอบด้วยอนุพันธ์เบนโซฟูแรน
MY130474A (en) Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
MXPA99006916A (en) Oil-free pharmaceutical compositions containing cyclosporin a

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed